Clinical Trials Logo

Solid Tumor, Recurrent clinical trials

View clinical trials related to Solid Tumor, Recurrent.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02644460 Completed - Clinical trials for Diffuse Intrinsic Pontine Glioma

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors

AflacST1501
Start date: February 2016
Phase: Phase 1
Study type: Interventional

This is a Phase I clinical trial evaluating abemaciclib (LY2835219), an inhibitor of cyclin dependent-kinases 4 and 6 (Cdk 4/6) in children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) (Stratum A) and in relapsed/refractory/progressive malignant brain (Grade III/IV, including DIPG; MBT) and solid tumor (ST) patients (Stratum B).